The Cannigma

MARCH 7, 2022

So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. Long before THC was discovered in the 1940s , CBN was first identified at the turn of the 20th century from a plant that was then known as Indian hemp. Converting THC to CBN happens through oxidation.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The use of ones containing THC was legalised across the UK in November 2018.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JULY 30, 2019

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. The US approval of Zogenix’s Fintepla, a potential competitor for GW’s drug, has been delayed but still lo… The European Pharmaceutical Review reports.

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Otherside Farms

JANUARY 24, 2019

Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. Source: FDA Approves Marijuana-Based Epilepsy Drug For Use On Kids In Clinical Trials. Although both studies will enroll 25 patients initially, the U.S. In the upcoming U.S.

Clinical Trials 45

Clinical Trials Epilepsy Marijuana Pharmaceutical 45

MMJ Recs

APRIL 1, 2024

Unlike its counterpart THC (tetrahydrocannabinol), CBD doesn’t produce psychoactive effects, making it an attractive option for those seeking therapeutic relief without the “high” associated with traditional marijuana use.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

NOVEMBER 29, 2019

Tetrahydrocannabinol (THC) is the element in cannabis that gets a person high. THC is the psychoactive compound in cannabis. But, THC has a similar chemical makeup with cannabidiol or CBD. CBD combats THC’s effects. THC alters communication functions. That’s why some people choose THC oil. THC Oil Benefits.

Oil 104

Oil THC Cannabinoids Research and Development 104

Veriheal

JULY 26, 2023

Eligible patients were granted access to low-THC marijuana oil. Its conversion into low-THC cannabis oil also allowed for treating many diseases. The first batch of authorized pharmaceutical retailers is expected to start selling between late August and early September.

Oil 98

Oil Patients Access THC 98

Veriheal

AUGUST 9, 2023

This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts. While many jurisdictions are still dilly-dallying on legal THC, CBD is legal and flourishing federally across 47 US states and the District of Columbia.

CBD 96

CBD Cannabinoids THC Extraction 96

Cannabis Law Report

JUNE 20, 2019

The compound responsible for the euphoric, mind-altering effect is tetrahydrocannabinol (THC). Department of Transportation (DOT) drug test includes THC, and its presence at defined levels constitutes a positive drug test. percent THC, they could contain high enough levels of THC to make a drug test positive.

THC 74

THC CBD Oil DEA 74

MMJ Recs

FEBRUARY 18, 2024

Research has identified cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol) as key players in the plant’s therapeutic effects. THC is known for its psychoactive properties, providing pain relief and promoting relaxation, while CBD offers non-psychoactive benefits, including anti-inflammatory and anti-anxiety effects.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

Cannabis Law Report

JULY 7, 2022

filed a petition requesting inter partes review of claims 1-13 of GW Pharmaceutical Ltd.’s s patent directed to the use of cannabinoids, including cannabidiol (“CBD”), in the treatment of certain types of epilepsy. The prior art asserted was clinical literature involving administration of CBD or tetrahydrocannabinol (“THC”).

Epilepsy 52

Epilepsy Pharmaceutical Treatment Cannabinoids 52

Veriheal

JULY 5, 2021

Cannabis is brimming with hundreds of active cannabinoids, but just two have really managed to steal the limelight – THC (tetrahydrocannabinol) and CBD (cannabidiol). However, as the recent UNM study demonstrates, THC also boasts medicinal qualities and could be a more suitable choice for fast and effective nausea relief.

THC 52

THC CBD Treatment Cannabinoids 52

MGC Pharma

DECEMBER 12, 2017

A word from Elad Segev, Manager of Breeding and Cultivation at MGC Pharmaceuticals. Tetrahydrocannabinol (THC) Tetrahydrocannabinol, or THC, is the component of the Cannabis plant that produces psychoactive effects that can range from racing thoughts to paranoia. You can learn more about that here.

Epilepsy 100

Epilepsy Cannabinoids Pharmaceutical THC 100

Cannabis Law Report

JULY 2, 2021

Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

Cannabis Law Report

AUGUST 4, 2022

Following the keenly anticipated June approval of its cannabis-derived Epidiolex, GW Pharmaceuticals $GWPH has finally launched the rare epilepsy drug in the United States. of tetrahydrocannabinol (THC), the component renowned for its ability to get people high. Press Release.

Epilepsy 52

Epilepsy Therapy Patients Treatment 52

Cannabis Law Report

JULY 24, 2019

It has been widely reported in the media that parents with children suffering from intractable epilepsy continue to experience difficulties in securing prescriptions for medical cannabis products containing THC. ” The Harley Street based clinic is the first of what will grow into a national network.

Epilepsy 40

Epilepsy Medicine Treatment Patients 40

Cannabis Law Report

JANUARY 16, 2022

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

TheAnswerPage

MAY 20, 2022

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

TheAnswerPage

AUGUST 19, 2021

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

Cannabis Law Report

APRIL 20, 2022

WROCLAW, Poland , April 19, 2022 /PRNewswire/ — Can4Med , a licensed wholesale specializing in medical products containing THC and cannabinoids has obtained Polish authorization to supply medical products and raw materials for cannabis pharmaceutical sales.

Pharmaceutical 52

Pharmaceutical Patients Medicine Epilepsy 52

TheAnswerPage

JUNE 14, 2021

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? ” GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

United Patients Group

APRIL 18, 2023

Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! The same cannot be said for alcohol or even caffeine (a more dangerous drug), which can lead to death if consumed excessively enough over time.

Research and Development 108

Research and Development Indica Treatment Conditions 108

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC. CBD for Anxiety. How to Use Cannabis for Anxiety.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

NOVEMBER 1, 2021

These include tetrahydrocannabinol (THC), a psychoactive substance that gives users a “high”. “It It is difficult to get 100 per cent pure CBD extracts from cannabis, and there’s a chance the products will contain traces of THC or other substances,” the source said. The city vows zero tolerance to drugs.

Wellness and Beauty 52

Wellness and Beauty CBD Clinical Trials Pharmaceutical 52

MedicalJane

OCTOBER 3, 2019

The United States Department of Defense and GW Pharmaceuticals are collaborating on a new clinical trial at the Montefiore Medical Center in New York. The study examines the effect of the cannabinoid Cannabidivarin, more commonly referred to as CBDV , on irritability and repetitive behaviors in children with autism spectrum disorder.

Clinical Trials 74

Clinical Trials Epilepsy Pharmaceutical Treatment 74

MMJ Recs

MAY 15, 2022

This initial MMJ legislation only allowed patients suffering from intractable epilepsy to use cannabis oil. In 2020, the law changed to allow patients with any medical condition to receive a doctor’s recommendation to use and purchase medical marijuana products containing a maximum 10 milligrams of THC.

Patients 52

Patients Marijuana Pharmaceutical Dispensary 52

The Cannigma

JUNE 15, 2021

THC is by far the most abundant and popular molecule in marijuana. The two most well known and common cannabinoids are THC and CBD, and while they won’t alter the aroma and colors of cannabis, they do interact with numerous receptor systems in the human body and have a range of effects. CBD vs THC. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

AUGUST 20, 2021

SLSG and its Swiss subsidiary, Savim SA , are developing specific proprietary strains of cannabis, with a focus on various areas, but particularly on future medical treatments for a variety of illnesses and diseases, including epilepsy, autism, and the different stages of COVID-19.

Research and Development 116

Research and Development Strains Treatment Epilepsy 116

Kind Meds (Cannabis Education Blog)

APRIL 29, 2019

This unique strain of low-THC, high-CBD marijuana allowed a little girl to truly experience life for the first time by dramatically reducing her seizures. Medical card in hand, Charlotte’s mother found a strain of medical cannabis with extremely low levels of THC and high levels of the CBD the couple hoped would help Charlotte.

Oil 86

Oil Strains Pharmaceutical Research and Development 86

Cannabis Law Report

JULY 9, 2021

Even though CBD comes from the same plant as tetrahydrocannabinol (THC), it is not a psychoactive compound so therefore it will not create a sensation of feeling ‘high’. Usually, mental health conditions are treated using pharmaceutical drugs, although they can result in side effects such as agitation, drowsiness, headaches, and insomnia.

Blood Pressure 105

Blood Pressure CBD Pets Oil 105

Cannabis Law Report

DECEMBER 22, 2019

Cannabis-based medicine is to be fast-tracked into the NHS , allowing thousands of people to be prescribed the drugs, including children with severe epilepsy. It contains plant-derived, strawberry-flavoured cannabidiol but not THC, which is responsible for the high from smoked cannabis.

Epilepsy 59

Epilepsy Medicine Treatment Pharmaceutical 59

Freedom Leaf

OCTOBER 15, 2018

Though it doesn’t get users high like THC-dominant products, CBD is all the rage these days due to its medical benefits and gray-area legality. On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Canna Care Docs

SEPTEMBER 18, 2020

These bills created the affirmative defense for possession of THC-A oil for the treatment of epilepsy. In 2017 Virginia began implementation of in-state production of THC-A and CBD oils. There can be a total of 5 Pharmaceutical Processors in the state, one for each Health Service area HSA.

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

United Patients Group

FEBRUARY 2, 2023

The ECS has been studied for its role in many diseases including cancer , epilepsy, chronic pain and multiple sclerosis (MS). The cannabinoids found within cannabis have been shown to help boost our natural defenses against illness by improving our overall health status rather than just treating symptoms like most pharmaceuticals do (i.e.,

Blood Pressure 103

Blood Pressure Sleep Chronic Pain Digestion 103

Veriheal

MAY 17, 2021

Please don’t further the lie by voting for any form of legalization beyond the pharmaceutical remedies already available under state law.” That is perhaps the biggest lie that is being perpetuated on the Alabama public today. ” State Doctors Oppose Legalization in Alabama.

Legalization 93

Legalization Pharmaceutical Therapy Chronic Pain 93

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Cannabinoids Epilepsy THC 74